Management of Influenza B Positive Fever and Cold
Antiviral Treatment: Oseltamivir
- The American Academy of Pediatrics recommends initiating oseltamivir 75 mg orally twice daily for 5 days in patients with influenza B who present within 48 hours of symptom onset and have fever >38°C 1
- The British Thoracic Society suggests that oseltamivir should be started if all three criteria are met: acute influenza-like illness confirmed as influenza B, fever >38°C in adults (>38.5°C in children), and symptomatic for ≤48 hours 2
- The dosing for children ≥12 months is as follows:
- Immunocompromised or elderly patients unable to mount adequate fever response may still benefit from oseltamivir despite lack of documented fever, according to the British Thoracic Society 2
- Oseltamivir reduces illness duration by approximately 24 hours, decreases symptom severity by up to 38%, and may reduce hospitalizations and subsequent antibiotic use, as reported by the British Thoracic Society 2
Antibiotic Management: When NOT to Use
- The British Thoracic Society recommends not routinely prescribing antibiotics for uncomplicated influenza B with cold symptoms and acute bronchitis 2
- Antibiotics should only be considered if there are signs of secondary bacterial infection, such as recrudescent fever, increasing breathlessness or dyspnea, new focal chest signs suggesting pneumonia, or high-risk patients with lower respiratory tract features 2, 6
- First-line oral antibiotic choices include co-amoxiclav and tetracycline (e.g., doxycycline), according to the British Thoracic Society 2, 6
Supportive Care
- The American Academy of Pediatrics suggests using antipyretics for fever control, adequate hydration, and rest and monitoring of symptoms 3
- A delayed antibiotic prescription strategy may be considered for selected previously healthy patients, with clear instructions to use only if illness is not settling after 2 days, worsening of symptoms occurs, or other specific criteria are met, as recommended by the British Thoracic Society 2